GLABELLAR FROWN LINES
Clinical trials for GLABELLAR FROWN LINES explained in plain language.
Never miss a new study
Get alerted when new GLABELLAR FROWN LINES trials appear
Sign up with your email to follow new studies for GLABELLAR FROWN LINES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New wrinkle treatment takes on botox in major trial
Symptom relief CompletedThis study tested a new injection called CU-20101 for moderate to severe frown lines between the eyebrows. It involved 554 adults and compared CU-20101 to Botox, a standard treatment. The goal was to see if CU-20101 works as well and is safe, including with repeated use.
Matched conditions: GLABELLAR FROWN LINES
Phase: PHASE3 • Sponsor: Cutia Therapeutics（Wuxi）Co.,Ltd • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
New injection shows promise for smoothing frown lines and Crow's feet
Symptom relief CompletedThis study tested a new injection called QM1114-DP in 25 adults with moderate to severe frown lines and crow's feet. Participants received one treatment and were asked to rate how much their appearance improved. The goal was to see if the treatment could make these wrinkles look …
Matched conditions: GLABELLAR FROWN LINES
Phase: PHASE3 • Sponsor: Galderma R&D • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
Nuceiva safety checked in 756 patients for frown lines
Knowledge-focused CompletedThis completed study looked at the long-term safety of Nuceiva (a botulinum toxin injection) for treating moderate-to-severe frown lines between the eyebrows. It involved 756 adults under 65 who received the treatment in real-world clinics. The main goal was to track any side eff…
Matched conditions: GLABELLAR FROWN LINES
Sponsor: Evolus, Inc. • Aim: Knowledge-focused
Last updated Jul 02, 2026 00:00 UTC